Company Deep Dive
Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.
7741.T
BuyPremium GrowerHOYA Corporation · Healthcare · Japan · $51.0B · Avg Vol: $156M/d
COMPANY DESCRIPTION
HOYA Corporation is a diversified Japanese technology and med-tech company, producing a wide range of products including eyeglass lenses, medical endoscopes, contact lenses, and data storage components. Its formidable competitive moat is built on advanced material science, precision manufacturing capabilities, and continuous R&D, enabling market-leading positions in several high-tech and healthcare segments. HOYA benefits from its diversified portfolio and expertise in high-precision optical and medical technologies.
FINANCIAL SUMMARY (JPY)
| Year | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 734.1B | 792.6B | 885.8B | 995.8B | 10.7% | 970.6B | 1.0T | 1.1T | 6.2% |
| EPS (JPY) | 446.45 | 469.76 | 515.48 | 581.26 | 743.93 | 13.6% | 724.16 | 776.14 | 874.25 | 8.4% |
| Shares | — | 354.0M | 350.5M | 342.8M | 335.5M | -5.2% | 334.5M | — | — | — |
| Debt | — | 24.6B | 29.2B | 37.3B | 42.2B | 19.8% | 44.8B | — | — | — |
| Equity | — | 818.3B | 967.8B | 974.0B | 1.0T | 7.6% | — | — | — | — |
| Op CF | — | 201.8B | 222.8B | 235.1B | 278.4B | 11.3% | 287.4B | — | — | — |
| Inv CF | — | -47.5B | -35.8B | -33.2B | -7.6B | — | — | — | — | — |
| Fin CF | — | -194.6B | -110.9B | -190.4B | -261.3B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 7741.T are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 7741.T | HOYA Corporation(you) | $51.0B | 69 | Buy |
| BDX | Becton, Dickinson and Company | $51.6B | 76 | Buy |
| WST | West Pharmaceutical Services, Inc. | $23.7B | 70 | Buy |
| ALC | Alcon Inc. | $34.8B | 51 | Hold |
| EL.PA | EssilorLuxottica Société anonyme | $85.9B | 53 | Hold |
| RMD | ResMed Inc. | $34.7B | 87 | Strong Buy |
| COLO-B.CO | Coloplast A/S | $16.2B | 66 | Buy |
| STMN.SW | Straumann Holding AG | $18.4B | 76 | Buy |
| DIM.PA | Sartorius Stedim Biotech S.A. | $22.3B | 55 | Hold |
| SRT.DE | Sartorius Aktiengesellschaft | $16.0B | 61 | Hold |
Peer medians: ROE 1.6% · P/E 23.1x · Gross margin 52.3%